newsfilter
← Latest News
GlobeNewswire·

SGRY Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Proposed Sale of Surgery Partners to HealthSpan Partners

SGRY
  • Wohl & Fruchter LLP is investigating the fairness of Surgery Partners, Inc.'s proposed sale to HealthSpan Partners for $23.50 per share in cash.
  • The sale was approved by a Special Committee of the SGRY Board, raising questions regarding the committee members' independence & disinterest.
  • SGRY's largest stockholder, Bain Capital Investors, will roll over its shares for equity in the surviving entity, a benefit not offered to public stockholders.
  • Public stockholders will be fully cashed out of their shares in the transaction.
  • Investors concerned about the sale's fairness may contact the firm at 866-833-6245 or via email at alerts@wohlfruchter.com.
  • The firm is examining whether the Board acted in stockholders' best interests, if the price is fair, & if all material information was disclosed.
  • Wohl & Fruchter LLP has over a decade of experience representing investors in fraud & corporate misconduct litigation.